DAA2236 |
CD14 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD14 |
134.9% Increase Gene Expression Level |
|
DAA1102 |
Myogenic Differentiation 1 |
Molecular |
frontal lobe |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA1082 |
Dipeptidyl-peptidase 8 |
Molecular |
frontal lobe |
Human |
DPP8 |
Increase DNA Methylation |
|
DAA2202 |
Clusterin increases with age |
Molecular |
frontal lobe |
Human |
CLU |
30.9% Increase Gene Expression Level |
|
DAA2203 |
Clusterin increases with age |
Molecular |
frontal lobe |
Human |
CLU |
56.5% Increase Gene Expression Level |
|
DAA2201 |
Clusterin increases with age |
Molecular |
frontal lobe |
Human |
CLU |
25.5% Increase Gene Expression Level |
|
DAA2235 |
toll interacting protein decreases with age |
Molecular |
frontal lobe |
Human |
TOLLIP |
36.3% Decrease Gene Expression Level |
|
DAA1078 |
Pipecolic Acid Oxidase |
Molecular |
frontal lobe |
Human |
PIPOX |
Increase DNA Methylation |
|
DAA2294 |
Fc fragment of IgG, receptor, transporter, alpha increases with age |
Molecular |
frontal lobe |
Human |
FCGRT |
89.3% Increase Gene Expression Level |
|
DAA2194 |
complement component 1, q subcomponent, A chain increases with age |
Molecular |
frontal lobe |
Human |
C1QA |
98.4% Increase Gene Expression Level |
|
DAA2287 |
CD163 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD163 |
283.0% Increase Gene Expression Level |
|
DAA2291 |
Fc fragment of IgG binding protein increases with age |
Molecular |
frontal lobe |
Human |
FCGBP |
212.4% Increase Gene Expression Level |
|
DAA2288 |
CD163 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD163 |
383.1% Increase Gene Expression Level |
|
DAA2195 |
complement component 1, q subcomponent, B chain increases with age |
Molecular |
frontal lobe |
Human |
C1QB |
166.8% Increase Gene Expression Level |
|
DAA2145 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
Molecular |
frontal lobe |
Human |
FCGR1B |
170.4% Increase Gene Expression Level |
|
DAA2197 |
complement component 1, s subcomponent increases with age |
Molecular |
frontal lobe |
Human |
C1S |
71.9% Increase Gene Expression Level |
|
DAA2154 |
complement component 4B increases with age |
Molecular |
frontal lobe |
Human |
C4B |
895.9% Increase Gene Expression Level |
|
DAA2198 |
complement component 3a receptor 1 increases with age |
Molecular |
frontal lobe |
Human |
C3AR1 |
89.0% Increase Gene Expression Level |
|
DAA2341 |
major histocompatibility complex, class I, B increases with age |
Molecular |
frontal lobe |
Human |
HLA-B |
36.5% Increase Gene Expression Level |
|
DAA2196 |
complement component 1, q subcomponent, C chain increases with age |
Molecular |
frontal lobe |
Human |
C1QC |
126.1% Increase Gene Expression Level |
|
DAA2153 |
complement component 4A increases with age |
Molecular |
frontal lobe |
Human |
C4A |
187.3% Increase Gene Expression Level |
|
DAA2380 |
major histocompatibility complex, class I, C increases with age |
Molecular |
frontal lobe |
Human |
HLA-C |
56.5% Increase Gene Expression Level |
|
DAA2343 |
major histocompatibility complex, class I, E increases with age |
Molecular |
frontal lobe |
Human |
HLA-E |
61.2% Increase Gene Expression Level |
|
DAA2345 |
major histocompatibility complex, class I, E increases with age |
Molecular |
frontal lobe |
Human |
HLA-E |
65.7% Increase Gene Expression Level |
|
DAA2234 |
toll interacting protein decreases with age |
Molecular |
frontal lobe |
Human |
TOLLIP |
57.8% Decrease Gene Expression Level |
|